Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

EPI-Net One Health reporting guideline for antimicrobial consumption and resistance surveillance data: a Delphi approach

  • Babu Rajendran, Nithya
  • Arieti, Fabiana
  • Mena-Benítez, Carla Alejandra
  • Galia, Liliana
  • Tebon, Maela
  • Alvarez, Julio
  • Gladstone, Beryl Primrose
  • Collineau, Lucie
  • De Angelis, Giulia
  • Duro, Raquel
  • Gaze, William
  • Göpel, Siri
  • Kanj, Souha S.
  • Käsbohrer, Annemarie
  • Limmathurotsakul, Direk
  • Lopez de Abechuco, Estibaliz
  • Mazzolini, Elena
  • Mutters, Nico T.
  • Pezzani, Maria Diletta
  • Presterl, Elisabeth
  • Renk, Hanna
  • Rodríguez-Baño, Jesús
  • Săndulescu, Oana
  • Scali, Federico
  • Skov, Robert
  • Velavan, Thirumalaisamy P.
  • Vuong, Cuong
  • Tacconelli, Evelina
Strategic and standardised approaches to analysis and reporting of surveillance data are essential to inform antimicrobial resistance (AMR) mitigation measures, including antibiotic policies. Targeted guidance on linking full-scale AMR and antimicrobial consumption (AMC)/antimicrobial residues (AR) surveillance data from the human, animal, and environmental sectors is currently needed. This paper describes the initiative whereby a multidisciplinary panel of experts (56 from 20 countries-52 high income, 4 upper middle or lower income), representing all three sectors, elaborated proposals for structuring and reporting full-scale AMR and AMC/AR surveillance data across the three sectors. An evidence-supported, modified Delphi approach was adopted to reach consensus among the experts for dissemination frequency, language, and overall structure of reporting; core elements and metrics for AMC/AR data; core elements and metrics for AMR data. The recommendations can support multisectoral national and regional plans on antimicrobials policy to reduce resistance rates applying a One Health approach., The EPI-Net project is funded by the COMBACTE-MAGNET and ECRAID-Base consortia. EPI-Net receives financial support from Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 115737, resources of which are composed of financial contribution from the European Union Seventh Framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries and Associations (EFPIA) companies' in-kind contribution, and the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 965313, respectively., Peer reviewed